122 related articles for article (PubMed ID: 20808316)
1. A new 16-membered tetraene macrolide JBIR-100 from a newly identified Streptomyces species.
Ueda JY; Hashimoto J; Yamamura H; Hayakawa M; Takagi M; Shin-ya K
J Antibiot (Tokyo); 2010 Oct; 63(10):627-9. PubMed ID: 20808316
[No Abstract] [Full Text] [Related]
2. Macrolides of the bafilomycin family produced by Streptomyces sp. CS.
Li J; Lu C; Shen Y
J Antibiot (Tokyo); 2010 Oct; 63(10):595-9. PubMed ID: 20823894
[TBL] [Abstract][Full Text] [Related]
3. Isolation and structure elucidation of Sch 642305, a novel bacterial DNA primase inhibitor produced by Penicillium verrucosum.
Chu M; Mierzwa R; Xu L; He L; Terracciano J; Patel M; Gullo V; Black T; Zhao W; Chan TM; McPhail AT
J Nat Prod; 2003 Dec; 66(12):1527-30. PubMed ID: 14695789
[TBL] [Abstract][Full Text] [Related]
4. JBIR-129 and -139, cytotoxic 34-membered polyol macrolides of microbial origin.
Kawahara T; Hwang JH; Izumikawa M; Hashimoto J; Takagi M; Shin-ya K
J Nat Prod; 2012 Oct; 75(10):1814-8. PubMed ID: 23039861
[TBL] [Abstract][Full Text] [Related]
5. [New findings on the biological activities of macrolides--antiviral effects of macrolide antibiotics].
Yamaya M; Suzuki T; Asada M; Sasaki T; Nishimura H
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():679-82. PubMed ID: 17455704
[No Abstract] [Full Text] [Related]
6. A novel macrolide compound from Streptomyces bingchenggensis: fermentation, isolation, structure elucidation and biological properties.
Xiang WS; Wang JD; Wang XJ; Zhang J
J Antibiot (Tokyo); 2009 Apr; 62(4):229-31. PubMed ID: 19282877
[No Abstract] [Full Text] [Related]
7. [Mechanism of biological activity of macrolide antibiotics--inhibitors of F0F1-ATPase].
Bibikova MV; Grammatikova NE; Kabanov AE; Sazykin IuO; Katlinskiĭ AV
Antibiot Khimioter; 2003; 48(12):33-9. PubMed ID: 15176103
[No Abstract] [Full Text] [Related]
8. Interaction of inhibitors of the vacuolar H(+)-ATPase with the transmembrane Vo-sector.
Páli T; Whyteside G; Dixon N; Kee TP; Ball S; Harrison MA; Findlay JB; Finbow ME; Marsh D
Biochemistry; 2004 Sep; 43(38):12297-305. PubMed ID: 15379568
[TBL] [Abstract][Full Text] [Related]
9. YO-001A, a new antifungal agent produced by Streptomyces sp. YO15-A001.
Yamamoto K; Futamura Y; Uson-Lopez RA; Aono H; Shimizu T; Osada H
J Antibiot (Tokyo); 2019 Dec; 72(12):986-990. PubMed ID: 31601980
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of novel analogues of archazolid: a highly potent simplified V-ATPase inhibitor.
Menche D; Hassfeld J; Sasse F; Huss M; Wieczorek H
Bioorg Med Chem Lett; 2007 Mar; 17(6):1732-5. PubMed ID: 17239591
[TBL] [Abstract][Full Text] [Related]
11. Stereochemical determination of Archazolid A and B, highly potent vacuolar-type ATPase inhibitors from the Myxobacterium Archangium gephyra.
Hassfeld J; Farès C; Steinmetz H; Carlomagno T; Menche D
Org Lett; 2006 Oct; 8(21):4751-4. PubMed ID: 17020294
[TBL] [Abstract][Full Text] [Related]
12. Understanding the inhibitory effect of highly potent and selective archazolides binding to the vacuolar ATPase.
Dreisigacker S; Latek D; Bockelmann S; Huss M; Wieczorek H; Filipek S; Gohlke H; Menche D; Carlomagno T
J Chem Inf Model; 2012 Aug; 52(8):2265-72. PubMed ID: 22747331
[TBL] [Abstract][Full Text] [Related]
13. New 24-membered macrolides SPA-6952A and B produced by Streptomyces sp.
Hosotani N; Kumagai K; Nakagawa H; Shimatani T; Saji I
J Antibiot (Tokyo); 2005 Jun; 58(6):409-11. PubMed ID: 16156518
[TBL] [Abstract][Full Text] [Related]
14. Macrolactin S, a new antibacterial agent with FabG-inhibitory activity from Bacillus sp. AT28.
Sohn MJ; Zheng CJ; Kim WG
J Antibiot (Tokyo); 2008 Nov; 61(11):687-91. PubMed ID: 19168985
[TBL] [Abstract][Full Text] [Related]
15. Identification of a new chondropsin class of antitumor compound that selectively inhibits V-ATPases.
Bowman EJ; Gustafson KR; Bowman BJ; Boyd MR
J Biol Chem; 2003 Nov; 278(45):44147-52. PubMed ID: 12944415
[TBL] [Abstract][Full Text] [Related]
16. Bafilomycin L, a new inhibitor of cholesteryl ester synthesis in mammalian cells, produced by marine-derived Streptomyces sp. OPMA00072.
Kobayashi K; Fukuda T; Usui T; Kurihara Y; Kanamoto A; Tomoda H
J Antibiot (Tokyo); 2015 Feb; 68(2):126-32. PubMed ID: 25095804
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and activity of the archazolid western hemisphere.
Tran AB; Melly GC; Doucette R; Ashcraft B; Sebren LJ; Havko N; Young JC; O'Neil GW
Org Biomol Chem; 2011 Oct; 9(22):7671-4. PubMed ID: 21931924
[TBL] [Abstract][Full Text] [Related]
18. A novel antimycin-like compound, JBIR-06, from Streptomyces sp. ML55.
Ueda JY; Nagai A; Izumikawa M; Chijiwa S; Takagi M; Shin-ya K
J Antibiot (Tokyo); 2008 Apr; 61(4):241-4. PubMed ID: 18503204
[TBL] [Abstract][Full Text] [Related]
19. Palmerolide macrolides from the Antarctic tunicate Synoicum adareanum.
Noguez JH; Diyabalanage TK; Miyata Y; Xie XS; Valeriote FA; Amsler CD; McClintock JB; Baker BJ
Bioorg Med Chem; 2011 Nov; 19(22):6608-14. PubMed ID: 21737286
[TBL] [Abstract][Full Text] [Related]
20. JBIR-52, a new antimycin-like compound, from Streptomyces sp. ML55.
Kozone I; Ueda JY; Takagi M; Shin-Ya K
J Antibiot (Tokyo); 2009 Oct; 62(10):593-5. PubMed ID: 19662084
[No Abstract] [Full Text] [Related]
[Next] [New Search]
